The Washington University Center for Diabetes Translational Research (CDTR) is soliciting applications for its Pilot and Feasibility Program. The purpose of this program is to advance translation research, preferably T3 or T4, in the areas of diabetes, prediabetes/metabolic syndrome, or obesity prevention or treatment. T3 research is translating clinical findings into everyday practice in real world settings; T4 research explores testing and implementing solutions at a population level. Letters of Intent are due on February 1, 2019 (5pm, CT)